Inhibition of protein kinase C delta attenuates allergic airway inflammation through suppression of PI3K/Akt/mTOR/HIF-1 alpha/VEGF pathway

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Choi, Yun Ho ^a   Jin, Guang Yu ^b   Li, Liang Chang ^b   Yan, Guang Hai ^b  

^a Chonbuk National University   (South Korea)

^b YANBIAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; 2 MORPHOLINO 8 PHENYLCHROMONE; CBO P11; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; OVALBUMIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C DELTA; RAPAMYCIN; ROTTLERIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; VASCULOTROPIN; CYTOKINE; PHOSPHOPROTEIN; PROTEIN KINASE INHIBITOR; SMALL INTERFERING RNA; TARGET OF RAPAMYCIN KINASE; VASCULOTROPIN A;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME REPRESSION; FEMALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; ASTHMA; CELL LINE; COMPLICATION; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; LUNG; LUNG LAVAGE; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TH2 CELL;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERSENSITIVITY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG; MICE; OVALBUMIN; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOPROTEINS; PROTEIN KINASE C-DELTA; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TH2 CELLS; TOR SERINE-THREONINE KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84896737466     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081773     Document Type: Article

References (60)

1. Galli SJ, Tsai M, Piliponsky AM (2008) The development of allergic inflammation. Nature 454: 445-454.
2. Medoff BD, Thomas SY, Luster AD (2008) T cell trafficking in allergic asthma: the ins and outs. Annu Rev Immunol 26: 205-232. (Pubitemid 351600375)
3. Boyce JA, Broide D, Matsumoto K, Bochner BS (2009) Advances in mechanisms of asthma, allergy, and immunology in 2008. J Allergy Clin Immunol 123: 569-574.
4. McCullagh A, Rosenthal M, Wanner A, Hurtado A, Padley S, et al. (2010) The bronchial circulation - worth a closer look: a review of the relationship between the bronchial vasculature and airway inflammation. Pediatr Pulmonol 45: 1-13.
5. Lee YC, Lee HK (2001) Vascular endothelial growth factor in patients with acute asthma. J Allergy Clin Immunol 107: 1106.
6. Kanazawa H (2007) VEGF, angiopoietin-1 and -2 in bronchial asthma: new molecular targets in airway angiogenesis and microvascular remodeling. Recent Pat Inflamm Allergy Drug Discov 1: 1-8.
7. Dey D, Basu D, Roy SS, Bandyopadhyay A, Bhattacharya S (2006) Involvement of novel PKC isoforms in FFA induced defects in insulin signaling. Mol Cell Endocrinol 246: 60-64. (Pubitemid 43238397)
8. Dempsey EC, Cool CD, Littler CM (2007) Lung disease and PKCs. Pharmacol Res 55: 545-559. (Pubitemid 46962310)
9. Alpert SE, Walenga RW, Mandal A, Bourbon N, Kester M (1999) 15-HETE-substituted diglycerides selectively regulate PKC isotypes in human tracheal epithelial cells. Am J Physiol 277: L457-464. (Pubitemid 29459664)
10. Page K, Li J, Zhou L, Iasvovskaia S, Corbit KC, et al. (2003) Regulation of airway epithelial cell NF-kappa B-dependent gene expression by protein kinase C delta. J Immunol 170: 5681-5689. (Pubitemid 36617861)
11. Cho SH, You HJ, Woo CH, Yoo YJ, Kim JH (2004) Rac and protein kinase C-delta regulate ERKs and cytosolic phospholipase A2 in FcepsilonRI signaling to cysteinyl leukotriene synthesis in mast cells. J Immunol 173: 624-631. (Pubitemid 38797392)
12. Langlois A, Chouinard F, Flamand N, Ferland C, Rola-Pleszczynski M, et al. (2009) Crucial implication of protein kinase C (PKC)-delta, PKC-zeta, ERK-1/2, and p38 MAPK in migration of human asthmatic eosinophils. J Leukoc Biol 85: 656-663.
13. Keith CT, Schreiber SL (1995) PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science 270: 50-51.
14. Raught B, Gingras AC, Sonenberg N (2001) The target of rapamycin (TOR) proteins. Proc Natl Acad Sci U S A 98: 7037-7044. (Pubitemid 32567899)
15. Tsang CK, Qi H, Liu LF, Zheng XF (2007) Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov Today 12: 112-124. (Pubitemid 46176669)
16. Saunders RN, Metcalfe MS, Nicholson ML (2001) Rapamycin in transplantation: a review of the evidence. Kidney Int 59: 3-16. (Pubitemid 32055209)
17. Mushaben EM, Kramer EL, Brandt EB, Khurana Hershey GK, Le Cras TD (2011) Rapamycin attenuates airway hyperreactivity, goblet cells, and IgE in experimental allergic asthma. J Immunol 187: 5756-5763.
18. Nagai H, Maeda Y, Tanaka H (1997) The effect of anti-IL-4 monoclonal antibody, rapamycin and interferon-gamma on airway hyperreactivity to acetylcholine in mice. Clin Exp Allergy 27: 218-224. (Pubitemid 27085424)
19. Fujitani Y, Trifilieff A (2003) In vivo and in vitro effects of SAR 943, a rapamycin analogue, on airway inflammation and remodeling. Am J Respir Crit Care Med 167: 193-198. (Pubitemid 36076079)
20. Eynott PR, Salmon M, Huang TJ, Oates T, Nicklin PL, et al. (2003) Effects of cyclosporin A and a rapamycin derivative (SAR943) on chronic allergic inflammation in sensitized rats. Immunology 109: 461-467. (Pubitemid 36783273)
21. Jiang BH, Semenza GL, Bauer C, Marti HH (1996) Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol 271: C1172-1180.
22. Ke Q, Costa M (2006) Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70: 1469-1480.
23. Wang GL, Semenza GL (1995) Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270: 1230-1237.
24. Hudson CC, Liu M, Chiang GG, Otterness DM, Loomis DC, et al. (2002) Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol 22: 7004-7014.
25. Minhajuddin M, Bijli KM, Fazal F, Sassano A, Nakayama KI, et al. (2009) Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells. J Biol Chem 284: 4052-4061.
26. Lee KS, Park SJ, Kim SR, Min KH, Jin SM, et al. (2006) Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma. J Allergy Clin Immunol 118: 403-409. (Pubitemid 44142718)
27. Kim SR, Lee KS, Park HS, Park SJ, Min KH, et al. (2010) HIF-1alpha inhibition ameliorates an allergic airway disease via VEGF suppression in bronchial epithelium. Eur J Immunol 40: 2858-2869.
28. Choi IW, Kim DK, Ko HM, Lee HK (2004) Administration of antisense phosphorothioate oligonucleotide to the p65 subunit of NF-kappaB inhibits established asthmatic reaction in mice. Int Immunopharmacol 4: 1817-1828.
29. Tournoy KG, Kips JC, Schou C, Pauwels RA (2000) Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin Exp Allergy 30: 79-85. (Pubitemid 30093884)
30. Li QF, Wang XR, Yang YW, Lin H (2006) Hypoxia upregulates hypoxia inducible factor (HIF)-3alpha expression in lung epithelial cells: characterization and comparison with HIF-1alpha. Cell Res 16: 548-558.
31. Bove PF, Wesley UV, Greul AK, Hristova M, Dostmann WR, et al. (2007) Nitric oxide promotes airway epithelial wound repair through enhanced activation of MMP-9. Am J Respir Cell Mol Biol 36: 138-146. (Pubitemid 46233465)
32. Zhai Y, Zhong Z, Chen CY, Xia Z, Song L, et al. (2008) Coordinated changes in mRNA turnover, translation, and RNA processing bodies in bronchial epithelial cells following inflammatory stimulation. Mol Cell Biol 28: 7414-7426.
33. Jiang H, Zhu YS, Xu H, Sun Y, Li QF (2010) Inflammatory stimulation and hypoxia cooperatively activate HIF-1{alpha} in bronchial epithelial cells: involvement of PI3K and NF-{kappa}B. Am J Physiol Lung Cell Mol Physiol 298: L660-669.
34. Brannan JD, Lougheed MD (2012) Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment. Front Physiol 3: 460.
35. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, et al. (1990) Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 247: 456-459.
36. Hamzaoui A, Ammar J, El Mekki F, Borgi O, Ghrairi H, et al. (2001) Elevation of serum soluble E-selectin and VCAM-1 in severe asthma. Mediators Inflamm 10: 339-342. (Pubitemid 34084414)
37. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, et al. (1989) Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59: 1203-1211. (Pubitemid 20024630)
38. Moschella PC, Rao VU, McDermott PJ, Kuppuswamy D (2007) Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCepsilon and PKCdelta, in adult cardiac muscle cells. J Mol Cell Cardiol 43: 754-766. (Pubitemid 350166390)
39. Tamaoki J, Yamawaki I, Tagaya E, Kondo M, Aoshiba K, et al. (1999) Effect of azelastine on platelet-activating factor-induced microvascular leakage in rat airways. Am J Physiol 276: L351-357. (Pubitemid 29102277)
40. Lee CG, Ma B, Takyar S, Ahangari F, Delacruz C, et al. (2011) Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 8: 512-515.
41. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, et al. (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276: 7614-7620.
42. Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, et al. (2004) Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10: 1095-1103. (Pubitemid 39424871)
43. Mizokami K, Kakeji Y, Oda S, Irie K, Yonemura T, et al. (2006) Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas. J Surg Oncol 94: 149-154. (Pubitemid 44267197)
44. Luque A, Turu M, Juan-Babot O, Cardona P, Font A, et al. (2008) Overexpression of hypoxia/inflammatory markers in atherosclerotic carotid plaques. Front Biosci 13: 6483-6490.
45. Huerta-Yepez S, Baay-Guzman GJ, Bebenek IG, Hernandez-Pando R, Vega MI, et al. (2011) Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis. Allergy 66: 909-918.
46. Land SC, Tee AR (2007) Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 282: 20534-20543. (Pubitemid 47100043)
47. Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, et al. (2009) The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30: 832-844.
48. Thomson AW, Turnquist HR, Raimondi G (2009) Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 9: 324-337.
49. Zhou L, Goldsmith AM, Bentley JK, Jia Y, Rodriguez ML, et al. (2005) 4E-binding protein phosphorylation and eukaryotic initiation factor-4E release are required for airway smooth muscle hypertrophy. Am J Respir Cell Mol Biol 33: 195-202. (Pubitemid 41473057)
50. Goncharova EA, Goncharov DA, Eszterhas A, Hunter DS, Glassberg MK, et al. (2002) Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J Biol Chem 277: 30958-30967. (Pubitemid 34970798)
51. Halayko AJ, Kartha S, Stelmack GL, McConville J, Tam J, et al. (2004) Phophatidylinositol-3 kinase/mammalian target of rapamycin/p70S6K regulates contractile protein accumulation in airway myocyte differentiation. Am J Respir Cell Mol Biol 31: 266-275. (Pubitemid 39180295)
52. Korfhagen TR, Le Cras TD, Davidson CR, Schmidt SM, Ikegami M, et al. (2009) Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 41: 562-572.
53. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, et al. (2005) Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115: 247-257. (Pubitemid 40385467)
54. Walters EH, Soltani A, Reid DW, Ward C (2008) Vascular remodelling in asthma. Curr Opin Allergy Clin Immunol 8: 39-43.
55. Hasaneen NA, Zucker S, Lin RZ, Vaday GG, Panettieri RA, et al. (2007) Angiogenesis is induced by airway smooth muscle strain. Am J Physiol Lung Cell Mol Physiol 293: L1059-1068. (Pubitemid 47572255)
56. Gibbs BF, Yasinska IM, Oniku AE, Sumbayev VV (2011) Effects of stem cell factor on hypoxia-inducible factor 1 alpha accumulation in human acute myeloid leukaemia and LAD2 mast cells. PLoS One 6: e22502.
57. Miyazawa M, Yasuda M, Fujita M, Kajiwara H, Hirabayashi K, et al. (2009) Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma. Pathol Int 59: 19-27.
58. Wan X, Shen N, Mendoza A, Khanna C, Helman LJ (2006) CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signaling. Neoplasia 8: 394-401. (Pubitemid 43830746)
59. Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105.
60. Frias MA, Thoreen CC, Jaffe JD, Schroder W, Sculley T, et al. (2006) mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol 16: 1865-1870. (Pubitemid 44354144)